Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3), a protein expressed in neuroendocrine tumors including small cell lung cancer (SCLC). This antibody serves as a foundational component in the development of the antibody-drug conjugate (ADC), Rovalpituzumab Tesirine, designed for targeted cancer therapy. Rovalpituzumab exhibits specific activity against SCLC, providing a strategic tool for research and therapeutic development in oncology.
Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3), a protein expressed in neuroendocrine tumors including small cell lung cancer (SCLC). This antibody serves as a foundational component in the development of the antibody-drug conjugate (ADC), Rovalpituzumab Tesirine, designed for targeted cancer therapy. Rovalpituzumab exhibits specific activity against SCLC, providing a strategic tool for research and therapeutic development in oncology.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
